Compound ID | 650
Synonym(s): PNU-101244
Class: Oxazolidinone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Was tested against Mycobacterium tuberculosis and S. aureus along with another promising compound PNU-100480. This compound was not as active against linezolid or PNU-100480 against either Mycobacterium tuberculosis or S. aureus |
| Description: | Huband MD, et al. In Vitro Activity of PNU-100480, PNU-101603, and PNU-101244: Novel Oxazolidinone Antibacterials versus Mycobacterium tuberculosis. 49th-ICAAC 2009 |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 2009 |
| Highest developmental phase: | Phase 2 (NCT05971602) |
| Development status: | Active |
| Reason Dropped: | Not as active as the lead compound PNU-100481 |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349985058 |
| Citation: |